by
Obagi
@ Tue, 16 Sep 2008 22:00:03 -0500
CNXT, AtheroGenics 3 ... Clinical Phase Movers: AGIX, From Trial Second AGI-1067 Type BIOS, NOVA, Trade Results APKT, Quarter Market Reports Technical Results of BeaconEquity.com Reports on ... 2008 Positive Alerts ANDES in Financial CHRD
CNXT, AtheroGenics 3 ... Clinical Phase Movers: AGIX, From Trial Second AGI-1067 Type BIOS, NOVA, Trade Results APKT, Quarter Market Reports Technical Results of BeaconEquity.com Reports on ... 2008 Positive Alerts ANDES in Financial CHRD